Home LiteratureArticle Details
PMID: 17261184 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Oestrogen receptor negative breast cancers exhibit high cytokine content.

Breast cancer research : BCR ·Vol. 9 ·No. 1 ·2007-00-00 ·Pages R15

Chavey C, Bibeau F, Gourgou-Bourgade S, Burlinchon S, Boissière F, Laune D, Roques S, Lazennec G

Abstract

An emerging hypothesis suggests that cytokines could play an important role in cancer as potential modulators of angiogenesis and leucocyte infiltration. A novel multiplexed flow cytometry technology was used to measure the expression of 17 cytokines (IL-1beta, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12 [p70], IL-13, IL-17, granulocyte colony-stimulating factor [CSF], granulocyte-macrophage CSF, IFN-gamma, monocyte chemoattractant protein [MCP]-1, macrophage inflammatory protein [MIP]-1beta, tumour necrosis factor [TNF]-alpha) at the protein level in 105 breast carcinoma. B lymphocyte, T lymphocyte and macrophage levels were determined by immunohistochemistry. Fourteen of the 17 cytokines were expressed in breast carcinoma, whereas only nine cytokines could be detected in normal breast. Most cytokines were more abundant in breast carcinoma than in normal breast, with IL-6, IL-8, granulocyte CSF, IFN-gamma, MCP-1 and MIP-1beta being very abundant. IL-2, IL-6, IL-8, IL-10, IFN-gamma, MCP-1, MIP-1beta and TNF-alpha, and to a lesser extent IL-1beta and IL-13 exhibited levels of expression that were inversely correlated to oestrogen receptor and progesterone receptor status. Most cytokines were not correlated with age at cancer diagnosis, tumour size, histological type, or lymph node status. However, IL-1beta, IL-6, IL-8, IL-10, IL-12, MCP-1 and MIP-1beta were more abundant in high-grade tumours than in low-grade tumours. In addition, IL-8 and MIP-1beta were expressed to a greater degree in HER2-positive than in HER2-negative patients. The expression of most of the studied cytokines was correlated to levels of activator protein-1, which is known to regulate numerous cytokines. Overexpression of MCP-1 and MIP-1beta were linked to B lymphocyte, T lymphocyte and macrophage infiltration, whereas high levels of IL-8 were correlated with high macrophage content in tumour. Moreover, IL-8 positive tumours exhibited increased vascularization. We found that multiple cytokines were overexpressed in oestrogen receptor negative breast carcinoma, and that the three major cytokines--MCP-1, MIP-1beta and IL-8--were correlated with inflammatory cell component, which could account for the aggressiveness of these tumours.

MeSH Terms
Breast Neoplasms/immunology,metabolism,pathology Case-Control Studies Cytokines/metabolism Female Flow Cytometry Gene Expression Profiling Humans Inflammation Neovascularization, Pathologic
Chemicals
Cytokines
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Chavey Carine
INSERM, U844, Site Saint Eloi, Bâtiment INM, University of Montpellier I, rue Augustin Fliche, Montpellier, F-34091, France.
Bibeau Frédéric
Gourgou-Bourgade Sophie
Burlinchon Sandrine
Boissière Florence
Laune Daniel
Roques Sylvie
Lazennec Gwendal
References (38)
38 references, click to expand
  1. Interleukin-1 family expression in human breast cancer: interleukin-1 receptor antagonist.
    Cancer Invest. 2000;18(4):293-302 PMID: 10808364
  2. Progesterone represses interleukin-8 and cyclo-oxygenase-2 in human lower segment fibroblast cells and amnion epithelial cells.
    Biol Reprod. 2003 Jul;69(1):331-7 PMID: 12672669
  3. Estrogen, a double-edged sword: modulation of TH1- and TH2-mediated inflammations by differential regulation of TH1/TH2 cytokine production.
    Curr Drug Targets Inflamm Allergy. 2004 Mar;3(1):97-104 PMID: 15032646
  4. The interleukin-1 family of cytokines and receptors in human breast cancer: implications for tumor progression.
    Int J Oncol. 2003 Aug;23(2):269-84 PMID: 12851675
  5. High incidence of interleukin 10 mRNA but not interleukin 2 mRNA detected in human breast tumours.
    Br J Cancer. 1997;75(12):1826-30 PMID: 9192989
  6. Expression of interleukin-1beta in human breast carcinoma.
    Cancer. 1997 Aug 1;80(3):421-34 PMID: 9241076
  7. Stress Hormones, Th1/Th2 patterns, Pro/Anti-inflammatory Cytokines and Susceptibility to Disease.
    Trends Endocrinol Metab. 1999 Nov;10(9):359-368 PMID: 10511695
  8. IL-8 expression and its possible relationship with estrogen-receptor-negative status of breast cancer cells.
    Oncogene. 2003 Jan 16;22(2):256-65 PMID: 12527894
  9. Concentration of interleukin-6 (IL-6), interleukin-8 (IL-8) and interleukin-10 (IL-10) in blood serum of breast cancer patients.
    Rocz Akad Med Bialymst. 2003;48:82-4 PMID: 14737948
  10. Estrogen regulates cytokine production and apoptosis in PMA-differentiated, macrophage-like U937 cells.
    J Cell Biochem. 2003 Sep 1;90(1):187-96 PMID: 12938167
  11. Clinical implications of expression of interleukin 8 related to angiogenesis in uterine cervical cancers.
    Cancer Res. 2000 May 15;60(10):2632-5 PMID: 10825134
  12. Global cancer statistics, 2002.
    CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108 PMID: 15761078
  13. Endocrine therapy of breast cancer.
    Annu Rev Med. 1975;26:353-63 PMID: 167649
  14. Tumour immunology.
    Curr Opin Immunol. 2003 Apr;15(2):129-30 PMID: 12633660
  15. CXC chemokines: the regulatory link between inflammation and angiogenesis.
    Trends Immunol. 2004 Apr;25(4):201-9 PMID: 15039047
  16. Significant correlation of monocyte chemoattractant protein-1 expression with neovascularization and progression of breast carcinoma.
    Cancer. 2001 Sep 1;92(5):1085-91 PMID: 11571719
  17. Estrogen receptor levels and survival of breast cancer patients. A study on patients participating in randomized trials of adjuvant therapy.
    Acta Oncol. 1987;26(2):95-100 PMID: 3300711
  18. Estrogen receptor impairs interleukin-6 expression by preventing protein binding on the NF-kappaB site.
    Nucleic Acids Res. 1997 Jun 15;25(12):2424-9 PMID: 9171095
  19. Dietary soy phytoestrogens and ERalpha signalling modulate interferon gamma production in response to bacterial infection.
    Clin Exp Immunol. 2004 Feb;135(2):219-25 PMID: 14738448
  20. 17Beta-estradiol inhibits MCP-1 production in human keratinocytes.
    J Invest Dermatol. 2003 Jun;120(6):1058-66 PMID: 12787135
  21. Interleukin 1 system and sex steroid receptor expression in human breast cancer: interleukin 1alpha protein secretion is correlated with malignant phenotype.
    Clin Cancer Res. 2003 Oct 15;9(13):4877-83 PMID: 14581361
  22. Changes in proinflammatory cytokine activity after menopause.
    Endocr Rev. 2002 Feb;23(1):90-119 PMID: 11844745
  23. Interleukin 6 acts as a paracrine growth factor in human mammary carcinoma cell lines.
    Clin Cancer Res. 1996 Jan;2(1):215-21 PMID: 9816109
  24. Identification of interleukin-8 as estrogen receptor-regulated factor involved in breast cancer invasion and angiogenesis by protein arrays.
    Int J Cancer. 2004 Apr 20;109(4):507-15 PMID: 14991571
  25. Expression pattern of the AP-1 family in breast cancer: association of fosB expression with a well-differentiated, receptor-positive tumor phenotype.
    Int J Cancer. 1999 Oct 22;84(5):533-8 PMID: 10502734
  26. Dissociative glucocorticoid activity of medroxyprogesterone acetate in normal human lymphocytes.
    J Clin Endocrinol Metab. 1999 Nov;84(11):4055-61 PMID: 10566649
  27. Estrogenic compounds suppressed interferon-gamma production in mouse splenocytes through direct cell-cell interaction.
    In Vitro Cell Dev Biol Anim. 2003 Sep-Oct;39(8-9):383-7 PMID: 14602042
  28. Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years.
    Br J Cancer. 1957 Sep;11(3):359-77 PMID: 13499785
  29. Estrogen decreases chemokine levels in murine mammary tissue: implications for the regulatory role of MIP-1 alpha and MCP-1/JE in mammary tumor formation.
    Endocrine. 2003 Nov;22(2):161-8 PMID: 14665721
  30. 17-beta-estradiol suppresses IL-2 and IL-2 receptor.
    Cytokine. 2001 Jun 21;14(6):324-33 PMID: 11497493
  31. The inhibition of synthesis of a beta-chemokine, monocyte chemotactic protein-1 (MCP-1) by progesterone.
    Biochem Biophys Res Commun. 1997 Oct 20;239(2):557-61 PMID: 9344869
  32. Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer.
    Clin Cancer Res. 2000 Aug;6(8):3282-9 PMID: 10955814
  33. Serum interleukin 6, plasma VEGF, serum VEGF, and VEGF platelet load in breast cancer patients.
    Clin Breast Cancer. 2002 Jan;2(4):311-5 PMID: 11899364
  34. Expression of cytokine messenger RNA in normal and neoplastic human breast tissue: identification of interleukin-8 as a potential regulatory factor in breast tumours.
    Int J Cancer. 1997 Sep 17;72(6):937-41 PMID: 9378554
  35. The role of cytokines in the epithelial cancer microenvironment.
    Semin Cancer Biol. 2002 Apr;12(2):113-20 PMID: 12027583
  36. Mechanisms underlying differential expression of interleukin-8 in breast cancer cells.
    Oncogene. 2004 Aug 12;23(36):6105-14 PMID: 15208657
  37. HER2 signaling modulates the equilibrium between pro- and antiangiogenic factors via distinct pathways: implications for HER2-targeted antibody therapy.
    Oncogene. 2006 Nov 2;25(52):6986-96 PMID: 16715132
  38. Immunomodulatory and transcriptional effects of progesterone through progesterone A and B receptors in Hec50co poorly differentiated endometrial cancer cells.
    J Soc Gynecol Investig. 2004 Oct;11(7):494-9 PMID: 15458748
Article Info
Journal
Breast cancer research : BCR
Abbr.
Breast Cancer Res
ISSN
1465-542X
Published
2007-00-00
Pages
R15
Language
English
Region
England
NLM ID
100927353
PMCID
PMC1851386
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]